Golden Meditech Announces Proposal for Name Change To Better Reflect Diversified Portfolio of Healthcare Businesses

HONG KONG, Feb. 11 /PRNewswire-Asia/ — Golden Meditech Company Limited
(“Golden Meditech,” or “the Group”; Stock Code: 801), China’s leading
integrated high-tech healthcare business, is pleased to announce today that
the Board of Directors (“the Board”) has proposed to change the Company’s name
into “Golden Meditech Holdings Limited”, subject to the shareholders’ approval
at the forthcoming EGM (Extraordinary General Meeting) and confirmation from
the Registrar of Companies in the Cayman Islands. (Note 1)

Mr. KAM Yuen, Chairman and CEO of the Group, said, “The proposed new name
will better reflect the Group’s diversified healthcare operations built around
its core competences, following the recent successful listings of its
affiliates, China Cord Blood Corporation (NYSE ticker symbol: CO), the first
and largest cord blood bank operator in China and FunTalk China Holding
Limited (NASDAQ ticker symbol: FTLK) in the United States.”

In addition to the two affiliates aforementioned, the Group’s other core
businesses also includes awholly-owned subsidiary Beijing Jingjing Medical
Equipment Co., Ltd., renowned as China’s first and largest manufacturer of
autologous blood recovery device, and a hospital management arm is the first
foreign-owned entity in China to offer nationwide hospital management and
consultancy services.

Mr. Kam further commented, “Across the integrated portfolio of healthcare
businesses that we currently operate, we enjoy dominant positions in the
various market segments. We believe the new name will better reflect our
corporate vision as underpinned by the Group’s strategic developments,
effectively highlighting the diversity and depth of the Group’s businesses
from investors’ point of view, and is in line with the interests of both the
Company and our Shareholders. Our expertise and in-depth knowledge in China
market has rendered us in an excellent position to capture the immense
opportunities arising from China’s rapidly expanding and thriving medical and
healthcare industries and beyond.”

    Note 1: A circular containing details of the proposed Change of Company
            Name, together with a notice of the EGM and the related proxy
            form, will be dispatched to the Shareholders as soon as
            practicable.

About the Company:

Golden Meditech Company Limited is China’s leading healthcare group and
the first hi-tech medical device enterprise that was publicly listed outside
of the PRC on the Stock Exchange of Hong Kong Limited (HKEX). Thanks to its
strengths in innovation and market expertise, as well as its ability in
capturing emerging market opportunities, Golden Meditech is a first-mover in
China in medical devices, cord blood banking services and innovative natural
herbal medicines segments and have established dominant positions in these
respective areas over the years. Going forward, the Company will continue its
pursuit in becoming China’s leading integrated medical group through organic
growth, acquisitions and strategic investments.

    For inquiry, please kindly contact:

     The Investor Relations Division
     Golden Meditech Company Limited
     Tel:    +852-3605-8138
     Fax:    +852-3605-8181
     Email:  ir@goldenmeditech.com

     Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong.

SOURCE Golden Meditech Company Limited